These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38642543)

  • 21. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M; Rafat B; Kolla G; Urbanoski K; Atkinson K; Bardwell G; Bonn M; Touesnard N; Henderson N; Bowles J; Boyd J; Brunelle C; Eeuwes J; Fikowski J; Gomes T; Guta A; Hyshka E; Ivsins A; Kennedy MC; Laurence G; Martignetti L; Nafeh F; Salters K; Tu D; Strike C; Pauly B; Werb D
    Int J Drug Policy; 2023 Oct; 120():104157. PubMed ID: 37574645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    J Urban Health; 2021 Feb; 98(1):59-69. PubMed ID: 33118145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?
    Weng J; Fairbairn N; Sutherland C; Johnson C; Nolan S
    J Addict Med; 2022 May-Jun 01; 16(3):258-260. PubMed ID: 34145188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
    Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
    Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada.
    Schmidt RA; Kaminski N; Kryszajtys DT; Rudzinski K; Perri M; Guta A; Benoit AC; Bayoumi AM; Challacombe L; Hales J; Kenny K; Kolla G; O'Reilly E; Sereda A; Rai N; Strike C
    Drug Alcohol Rev; 2023 Nov; 42(7):1825-1837. PubMed ID: 37718646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
    Fischer B; Pang M; Jones W
    Subst Abuse Treat Prev Policy; 2020 Feb; 15(1):14. PubMed ID: 32066470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Navigating social norms of injection initiation assistance during an overdose crisis: A qualitative study of the perspectives of people who inject drugs (PWID) in Vancouver, Canada.
    Olding M; Werb D; Guise A; Small W; McNeil R
    Int J Drug Policy; 2019 Jul; 69():24-33. PubMed ID: 31029914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A concept mapping study of service user design of safer supply as an alternative to the illicit drug market.
    Pauly B; McCall J; Cameron F; Stuart H; Hobbs H; Sullivan G; Ranger C; Urbanoski K
    Int J Drug Policy; 2022 Dec; 110():103849. PubMed ID: 36215793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
    Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
    Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
    Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
    Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada.
    Bardwell G; Lappalainen L
    Can J Public Health; 2021 Aug; 112(4):733-736. PubMed ID: 33782915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Youth Perspectives of Prescription Pain Medication in the Opioid Crisis.
    Harbaugh CM; Vu JV; DeJonckheere M; Kim N; Nichols LP; Chang T
    J Pediatr; 2020 Jun; 221():159-164. PubMed ID: 32143929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada.
    Gagnon M; Rudzinski K; Guta A; Schmidt RA; Kryszajtys DT; Kolla G; Strike C
    Harm Reduct J; 2023 Jun; 20(1):81. PubMed ID: 37380995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.